CBNW, launched in September 2026, is a free to subscribe, daily news feed, covering the Chinese biotechnology sector, and published by 80th Atom

 

Targeted at business development executives seeking assets and deals in China, CBNW provides a comprehensive view of deals, clinical developments, and financings of Chinese biotech companies. 

 

CBNW is edited by Adam Michael, a seasoned journalist - former European News Editor at BioCentury, reporter for Nature Biotechnology, and freelancer for multiple UK National Newspapers, including the Financial Times.